|Robert J. Palmisano|
President & CEO
Robert J. Palmisano was appointed President and Chief Executive Officer and Executive Director of Wright Medical Group N.V. effective October 2015 in connection with the merger of Wright Medical Group, Inc. and Tornier N.V. Mr. Palmisano also serves as President and Chief Executive Officer of Wright Medical Group, Inc., a position he has held since September 2011. He has significant experience leading publicly-traded medical device companies, serving as President and Chief Executive Officer of ev3 Inc., a global endovascular device company, from April 2008 to July 2010, when it was acquired by Covidien plc. Prior to leading ev3, Mr. Palmisano was President and Chief Executive Officer of IntraLase Corp. from 2003 to 2007, and previously President and Chief Executive Officer of MacroChem Corporation from 2001 to 2003. Earlier in his career, he served as President and Chief Executive Officer of Summit Technology Inc. until it was acquired by Alcon Inc., and in various executive positions at Bausch & Lomb Incorporated. Mr. Palmisano currently serves as a member of the board of directors of Avedro, Inc., a privately held ophthalmic medical device and pharmaceutical company, and the Providence College Board of Trustees. During the past five years, Mr. Palmisano previously served on the board of directors of Bausch & Lomb, a privately-held company, and ev3 Inc., Osteotech, Inc., and Abbott Medical Optics, Inc., all public companies. Mr. Palmisano holds a B.A. degree in Political Science from Providence College.